Orthometrix, Inc.
OMRX · OTC
12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.05 | 0.00 | 0.03 |
| FCF Yield | 17.61% | 62.78% | 489.15% | -11.56% |
| EV / EBITDA | 4.53 | 7.59 | -5.87 | -4.59 |
| Quality | ||||
| ROIC | 39.97% | -82.24% | 7.43% | 0.00% |
| Gross Margin | 69.60% | 69.00% | 61.72% | 44.42% |
| Cash Conversion Ratio | 0.79 | 4.02 | -0.79 | 0.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.97% | -23.66% | -34.94% | 16.74% |
| Free Cash Flow Growth | 40.77% | 28.34% | 0.00% | 82.50% |
| Safety | ||||
| Net Debt / EBITDA | 0.70 | 4.74 | -5.61 | -0.02 |
| Interest Coverage | 3.83 | 1.80 | -2.09 | 0.64 |
| Efficiency | ||||
| Inventory Turnover | 4.70 | 4.54 | 2.06 | 2.44 |
| Cash Conversion Cycle | 138.23 | -144.34 | -1,850.63 | -197.08 |